Details About Generic Salt ::  Butalbit

Main Medicine Class:: Nonnarcotic analgesic   

(BYOO-TAL-bih-tuhl/uh-seet-uh-MIN-oh-fen/kaff-EEN)

Esgic, Esgic-Plus, Fioricet, Margesic, Medigesic, Repan, Triad

Class: Nonnarcotic analgesic

 

Drugs Class ::

 Action Butalbital has generalized depressant effect on CNS and, in very high doses, has peripheral effects. Acetaminophen has analgesic and antipyretic effects; its analgesic effects may be mediated through inhibition of prostaglandin synthetase enzyme complex. Caffeine is thought to produce constriction of cerebral blood vessels.

Indications for Drugs ::

 Indications Relief of symptom complex of tension (or muscle contraction) headache.

Drug Dose ::

 Route/Dosage

ADULTS: PO 1 to 2 tablets or capsules q 4 hr; maximum is 6 tablets or capsules/day.

Contraindication ::

 Contraindications Hypersensitivity to acetaminophen, caffeine or barbiturates; porphyria.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy in children < 12 yr not established. Drug dependency: Prolonged use may produce drug tolerance and dependency (psychologic and physical).

PATIENT CARE CONSIDERATIONS

Drug Side Effects ::

 Adverse Reactions

CNS: Drowsiness; dizziness; lightheadedness; confusion. DERM: Rash. GI: Nausea; vomiting; flatulence.

Drug Mode of Action ::  

 Action Butalbital has generalized depressant effect on CNS and, in very high doses, has peripheral effects. Acetaminophen has analgesic and antipyretic effects; its analgesic effects may be mediated through inhibition of prostaglandin synthetase enzyme complex. Caffeine is thought to produce constriction of cerebral blood vessels.

Drug Interactions ::

 Interactions

Beta-blockers (eg, propranolol), corticosteroids, doxycycline, estrogens (including oral contraceptives), felodipine, griseofulvin, nifedipine, phenylbutazone, quinidine, theophylline, warfarin: Effects of these drugs may be decreased. Carbamazepine, sulfinpyrazone: May increase risk of hepatotoxicity. MAO inhibitors: May increase CNS effects. Other CNS depressants (ethanol, narcotics, general anesthetics, tranquilizers, sedative-hypnotics): Increased drowsiness, dizziness and other CNS depressive effects may occur. Tricyclic antidepressants: Antidepressant effect may decrease.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies.
• Assess pain before administration to establish baseline.
• Assess vital signs before administration.
• Assess related factors that may precipitate or worsen pain such as anxiety, fear, or stress.
• Administer scheduled dose before pain is severe.
• Utilize adjunct pain relief measures, such as massage, positioning and maintaining quiet environment to enhance effectiveness.
• Assess therapeutic effectiveness 1 hr after dose based on patient report of relief. Do not rely on objective signs.
• Reassess vital signs.
• Assess for dizziness, sedation or euphoria.
• Record degree and duration of pain relief. Notify physician if product is ineffective.
• Institute safety precautions if drowsiness or sedation occurs.

OVERDOSAGE: SIGNS & SYMPTOMS   Blood dyscrasias, respiratory depression, hepatic damage, drowsiness, confusion, coma, hypotension, tachycardia, hypovolemic shock, nausea, vomiting, insomnia, restlessness, tremor

Drug Storage/Management ::

 Administration/Storage

• Give with food or water.
• Store in airtight, light-resistant container at room temperature.

Drug Notes ::

 Patient/Family Education

• Caution patient that dependency/tolerance may result from regular long-term use.
• Tell patient to take drug with full glass of water.
• Instruct patient not to discontinue drug abruptly after long-term regular use.
• Caution patient to avoid intake of alcoholic beverages and other CNS depressants without physician approval.
• Advise patient to avoid any hazardous activity (driving or smoking) if dizziness, drowsiness or a decrease in mental acuity occurs.
• Warn patient that orthostatic hypotension may occur. Instruct patient to change positions slowly and to sit or lie down if symptoms occur.
• Instruct patient not to take otc or other medications unless directed by physician.
• Inform patient to report the following symptoms to physician: Persistent or recurrent pain before next scheduled dose, difficulty breathing, increased drowsiness, vomiting or yellowing of skin or gums.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.